Q32 Bio Inc.
USD13.05
-1.08 (-7.67%)
CEO
Jodie Pope Morrison
IPO Date
2018-03-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$14.16
Prev. Close
$14.14
Day Low
$12.76
Day High
$14.50
52W Low
$1.34
52W High
$15.02
Market Cap
$0.17B
Volume
0.15M
| 9,810 |
| $12.64 |
| 16 Jun 2026 | Manke Isaac | director | A-Award | Acquired | 9,810 | $12.64 |
| 16 Jun 2026 | TZIANABOS ARTHUR | director | A-Award | Acquired | 9,810 | $12.64 |
| 16 Jun 2026 | GRAYZEL DAVID S. | director | A-Award | Acquired | 9,810 | $12.64 |
| 16 Jun 2026 | Thistle Mary | director | A-Award | Acquired | 9,810 | $12.64 |
| 16 Jun 2026 | Xu Diyong | director, 10 percent owner: | A-Award | Acquired | 9,810 | $12.64 |
| 16 Jun 2026 | Lundberg Sven Ante | director | A-Award | Acquired | 9,810 | $12.64 |
| 8 Jun 2026 | Atlas Venture Opportunity Fund Ill, L.P. | other: See Remarks | Disposed | 0 | $0.00 |
| 1 Jun 2026 | Xu Diyong | director, 10 percent owner: | P-Purchase | Acquired | 1,250,000 | $8.00 |